Periodic Reporting for period 1 - SERENITY (Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life)

Despite the fact that antithrombotic therapy (ATT) has little or even negative effects on the well-being of cancer patients during their last year of life, stopping ATT is rare in clinical practice. In contrast, ATT is often continued until death, resulting in excess bleeding...